Skip to content

Effect of transcranial stimulation on painful physical symptoms in patients with major depressive disorder

Effect of transcranial stimulation on painful physical symptoms in patients with major depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064144
Enrollment
Unknown
Registered
2022-09-27
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

group1:Transcranial Stimulation on M1
group2:Transcranial Stimulation on DLPFC
group3:Sham Stimulation

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria that meet the ICD-10 diagnostic criteria for depressive disorder; 2. The Hamilton Depression Scale (L7-item version) score >= 8; 3. Aged 18-75 years with more than 5 years of formal education; 4. All participants signed a informed consent. 5. Right-handedness, determined by Edinburgh Handedness Scale; 6. With somatic pain symptoms and is currently experiencing pain of any kind.

Exclusion criteria

Exclusion criteria: 1. Prior medical history of central nervous system disease, severe head injury, active or progressive neurodegenerative disease or physical disease and/or other severe medical conditions; 2. History of electroconvulsive therapy within the last six months; 3. Substance abuse or dependence; 4. Comorbidities associated with other sleep disorders (e.g., sleep apnea) or worked a night shift or had a rotating work schedule within the last three months; 5. With MAOI within four weeks; 6. Pregnant and lactation; 7. Recent use of antibiotics or probiotic synbiotics within 30 days of study participation; history of gastrointestinal surgery or severe congenital abnormalities.

Design outcomes

Primary

MeasureTime frame
Short-form of Mc Gill pain questionnaire;Hamilton Depression Scale;Hamilton Anxiety Scale;Polysomnography;Electroencephalogram;Somatic Self-rating Scale;Gastrointestinal Symptom Rating Scale;tDCS Adverse Effects Questionnaire;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
BMI-based Silhouette Matching Test;Temporal Experience of Pleasure Scale; Dimensional Anhedonia Rating Scale;Snaith-Hamilton pleasure scale;Acceptance and Ac-tion Questionnaire-2nd Edition;Connor-Davidson resilience scale;Childhood Trauma Questionnaire;Cognitive Flexibility Inventory;Emotion Regulation Questionnaire;The Epworth Sleeping Scale;Insomnia Severity Index;Properties of the Body Perception Questionnaire-Short Form;The Depression Anxiety Stress Scale;fatigue severity scale;Bech-Rafaelsen Mania Rating Scale;Columbia-Suicide Severity Rating Scale;Multidimensional Dream Inventory;Nightmare Distress Questionnaire ;dream recall frequency;

Countries

China

Contacts

Public ContactQi Zhang

Wuxi Mental Health Center

1811110636@bjmu.edu.cn13051296767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026